Aeglea Biotherapeutics shares owned by Royal Bank of Canada
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Royal Bank of Canada
from 13F filings
Historical chart of Royal Bank of Canada investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Royal Bank of Canada
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $131k | 7.9k | 16.59 |
| 2025-06-30 | $116k | 8.5k | 13.64 |
| 2025-03-31 | $35k | 2.2k | 16.11 |
| 2024-12-31 | $94k | 4.0k | 23.37 |
| 2024-09-30 | $113k | 3.8k | 29.91 |
| 2024-06-30 | $77k | 3.3k | 23.65 |
| 2024-03-31 | $2.0k | 56 | 35.71 |
| 2023-09-30 | $5.0k | 437 | 11.44 |